Why Do Heart and Skin Cells Produce Different Outputs From the Same DNA? DeepMind Unveils AlphaGenome 2
Google DeepMind has launched AlphaGenome 2, pressing on to tackle a notoriously hard problem: why different cells read distinct results from the exact same set of DNA. Few public details are available right now, but this research direction is well worth following.

Figure: Schematic of Google's AlphaGenome Atlas.
Google DeepMind has released AlphaGenome 2. It succeeds the AlphaGenome launched last year, with a clear goal: to understand how DNA variations affect different cell types, and give scientists access to a far more granular view of genomic function. The Verge's report calls this a famously intractable problem that could yield critical clues about the root causes of diseases and point to new therapeutic directions.
The background is straightforward. Nearly every cell in the human body carries the full identical set of DNA, but cardiomyocytes, skin cells, and immune cells that are fighting off infections turn different genes on or off. These gene switch patterns also shift as cell states change. Disease-related genetic variants often do not land in the regions that directly code for proteins. Determining exactly which cell type, which gene, and under what conditions a given variant exerts its effect is one of the most thorny unsolved problems in genomics. What AlphaGenome 2 aims to do is incorporate this cell-type-specific context into its predictions.
The real hard part for this category of models is making predictions that map to concrete cell types and specific regulatory elements, and that can be validated by laboratory experiments. A generic single score is far from enough. For AI practitioners, it is worth examining how the model processes long sequences, integrates cell type conditioning, and delivers interpretability; for general readers, you can think of it as a high-resolution map for how the genome is read. A map is only useful if its coordinates are reliable.
The public information available so far is mostly the launch announcement and high-level overview. Specific benchmarks, data coverage, and level of public access will be clarified in follow-up materials from DeepMind. Do not rush to treat full genome understanding as a solved problem. The harder the underlying problem is, the more valuable new progress on it becomes to follow.
Original source: The Verge
发布时间: 2026-11-11 23:00